Kansas City Cancer Center - Central

Kansas City, Missouri 64111

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed